Moving closer to a prognostic DNA methylation signature in colon cancer

Clinical Cancer Research

Volumn 17, Issue 6, 2011, Pages 1215-1217

  Carmona, F Javier ^a   Esteller, Manel ^a,b,c  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MICRORNA; PROTEIN MLH1; PROTEIN P53;

CANCER MORTALITY; CANCER RECURRENCE; CANCER RESEARCH; CANCER SURVIVAL; CD109 GENE; CELL GROWTH; COLON CANCER; CPG ISLAND; DNA METHYLATION; EVL GENE; EXTRACELLULAR MATRIX; FLNC GENE; GENE; GENE DELETION; GENE EXPRESSION PROFILING; GENE INSERTION; GENE MUTATION; GENE SILENCING; GENETIC ANALYSIS; HUMAN; IGFBP3 GENE; METASTASIS POTENTIAL; MISMATCH REPAIR; MLH1 GENE; NOTE; NRCAM GENE; NTNG GENE; ONCOGENE K RAS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; RNA ANALYSIS; TUMOR SUPPRESSOR GENE;

COHORT STUDIES; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; HUMANS; MEDICAL ONCOLOGY; PROGNOSIS; RECURRENCE;

EID: 79952711083     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-3446     Document Type: Note

References (12)

1. Yi JM, Dhir M, Van Neste L, Downing SR, Jana Jeschke J, Glockner S, et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Can Res 2011;17:1535-45.
2. Esteller M. Epigenetics in cancer. N Engl J Med 2008;358:1148-59.
3. Carmona FJ, Esteller M. Epigenomics of human colon cancer. Mutat Res 2010;693:53-60.
4. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 1998;95:6870-5. (Pubitemid 28278073)
5. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-7. (Pubitemid 29086728)
6. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, et al. Inactivation of the DNA repair gene O6-methylguanine- DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000;60:2368-71. (Pubitemid 30262424)
7. Esteller M, Risques RA, Toyota M, Capella G, Moreno V, Peinado MA, et al. Promoter hypermethylation of the DNA repair gene O(6)-methyl-guanine-DNA methyltransferase is associated with the presence of G: C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001;61:4689-92.
8. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13. (Pubitemid 350134889)
9. Barkan D, Green JE, Chambers AF. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 2010;46:1181-8.
10. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, et al. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 2008;100:1734-8.
11. Jorissen RN, Gibbs P, Christie M, Prakash S, Lipton L, Desai J, et al. Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clin Cancer Res 2009;15:7642-51.
12. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjt L, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008;68:6416-24.